There has been a huge announcement this week from Asep Medical Holdings.
Yesterday, the company announced an exclusive licensing arrangement for a patented and novel AI-Driven sepsis diagnosis technology developed at UBC. This technology will allow $ASEP to make a major impact on the lives of patients who acquire the deadly syndrome using its novel diagnostic test, Sepset.
Sepset has the ability to diagnose sepsis infections in about an hour compared to the current diagnosis time of 24-36 hours, potentially saving millions of lives globally.
With the global sepsis diagnostics market expected to reach $975 million by 2026, the potential for $ASEP to become a leader in the field equates to an extremely high potential growth opportunity.
$ASEP.C is currently trading at $.38 and the company is valued at $21.33 million.
https://ceo.ca/@newswire/asep-medical-holdings-inc-announces-an-exclusive-licensing